Skip to main content
Fig. 1 | Lipids in Health and Disease

Fig. 1

From: International practice patterns of dyslipidemia management in patients with chronic kidney disease under nephrology care: is it time to review guideline recommendations?

Fig. 1

Prevalence and intensity of statin use by country and A CKD stage or B cardiovascular risk. Atorvastatin and rosuvastatin are categorized as high intensity; all other statins are categorized as low intensity: simvastatin, lovastatin, pravastatin, fluvastatin, cerivastatin, and pitavastatin. The composite cardiovascular (CV) risk is based on comorbidity burden (any history of coronary disease, diabetes, or ischemic stroke) and age

Back to article page